Biochemical Reagent
-
BA8983 PRN694Summary: PRN694 is an irreversible, highly potent and selective, potent covalently bound dual inhibitor of interleukin 2-inducible cell kinase, resting lymphocyte kinase. - BA8984 SoquelitinibSummary: Soquelitinib (CPI-818) is a highly selective covalent inhibitor.
- BA8985 GNE-9822Summary: GNE-9822 is an orally effective and selective inhibitor.
- BA8986 GSK-2250665ASummary: GSK-2250665A is a selective inhibitor.
- BA8987 VorolanibSummary: Vorolanib (CM082) is an orally active, potent inhibitor.
- BA8988 TrapidilSummary: Trapidil is a vasodilator.
- BA8989 ZeteletinibSummary: Zeteletinib (BOS-172738; DS-5010) is an orally effective, selective kinase inhibitor with nanomolar potency against and >300-fold selectivity for VEGFR2.
- BA8990 AnsornitinibSummary: Ansornitinib is an orally active dual kinase inhibitor that inhibits platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR2).
- BA8991 NVP-ACC789Summary: An inhibitor.
- BA8992 CT52923Summary: CT52923 is a selective platelet-derived growth factor receptor antagonist with oral activity.